Aurora Oncology, Inc.
Golden, CO · Biotech · Private
DTEGF, a diphtheria toxin–EGF fusion protein for intravesical bladder cancer treatment
- Grants
- $3.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of Antimicrobial Peptides to Target Gram-negative Pathogens | $299,971 | |
| Federal grant | Department of Health and Human Services · Phase II · DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer | $299,937 | |
| Federal grant | Department of Health and Human Services · Phase II · DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer | $2,000,700 | |
| Federal grant | Department of Health and Human Services · Phase II · DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer | $999,955 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1287 | ELIXERA, INC. | — | — |
| 1288 | Distributed Bio, Inc. | — | — |
| 1289 | PIPA LLC | — | — |
| 1290 | Aurora Oncology, Inc. | — | — |
| 1291 | RIDGELINE THERAPEUTICS LLC | — | — |
| 1292 | BIOORG3.14 LLC | — | — |
| 1293 | SUNOMIX THERAPEUTICS | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.